Collegium Pharmaceutical (COLL) Amortization of Deferred Charges (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Amortization of Deferred Charges of $819000.0 for Q1 2026, down 40.09% year-over-year from $1.4 million in Q1 2025, and down 35.82% quarter-over-quarter from $1.3 million in Q4 2025.
Collegium Pharmaceutical (COLL) Amortization of Deferred Charges (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Amortization of Deferred Charges history runs 9 years deep, the most recent figure standing at $819000.0 for Q1 2026.
- In Q1 2026, Amortization of Deferred Charges fell 40.09% year-over-year to $819000.0; the TTM figure through Mar 2026 stood at $4.3 million (down 15.53% YoY), while the FY2025 annual figure was $5.3 million, down 11.22% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $819000.0, down from $1.3 million in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $2.5 million in Q2 2022, with the low at $819000.0 in Q1 2026.
- The 5-year median for Amortization of Deferred Charges is $1.4 million (2024), against an average of $1.6 million.
- The sharpest annual moves came in 2022 and 2024: Amortization of Deferred Charges soared 205.91% in 2022, then tumbled 48.0% in 2024.
- Collegium Pharmaceutical's Amortization of Deferred Charges stood at $2.4 million in 2022, then slipped by 17.62% to $2.0 million in 2023, then dropped by 27.46% to $1.4 million in 2024, then dropped by 10.39% to $1.3 million in 2025, then sank by 35.82% to $819000.0 in 2026.
- Business Quant data shows COLL's Amortization of Deferred Charges at $819000.0 in Q1 2026, $1.3 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Collegium Pharmaceutical | 897.87 Mn | 748.55 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 784,000.00 |
| Jun 30, 2026 | 784,000.00 |
| Mar 31, 2026 | 819,000.00 |
| Mar 31, 2026 | 819,000.00 |
| Dec 31, 2025 | 1.28 Mn |
| Dec 31, 2025 | 1.28 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.37 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | 947,000.00 |
| Sep 30, 2024 | 947,000.00 |
| Jun 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.32 Mn |
| Mar 31, 2024 | 1.78 Mn |
| Mar 31, 2024 | 1.78 Mn |